TearLab Corporation announced that Adam Szaronos has been appointed as Chief Executive Officer by the company's Board of Directors, effective immediately. Mr. Szaronos has been instrumental in leading teams and bringing innovations to market to address unmet needs throughout eye care. Mr. Szaronos joined TearLab's executive team as Chief Commercial Officer in 2020 after the company was acquired by investment firm Accelmed Partners. In that role, he was responsible for overseeing the commercial restructuring and relaunch of TearLab's global diagnostics business. Prior to TearLab, Mr. Szaronos held various sales, marketing, and strategic management positions of increasing responsibility at Alcon, with leadership experience throughout both the surgical and vision care businesses. His most recent role was as Alcon's Head of Dry Eye Devices, where he launched and managed the company's new business unit.